He was responding to a question raised at the Lok Sabha on Thursday regarding the government’s research on monitoring the ...
Roche (RHHBY) announced results from the Phase IIb PADOVA study investigating prasinezumab in 586 people with early-stage Parkinson’s disease, treated for a minimum of 18 months while on stable ...
Dr Vermeij is an expert on marine molluscs, the shells of which he can study in detail by touch. In the 1970s he realised ...